Christopher Exley Selected Research

Cognitive Dysfunction

12/2019	Egg White Hydrolysate as a functional food ingredient to prevent cognitive dysfunction in rats following long-term exposure to aluminum.
1/2017	Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity.
1/2015	Bumblebee pupae contain high levels of aluminium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher Exley Research Topics

Disease

35	Alzheimer Disease (Alzheimer's Disease) 09/2021 - 12/2001
13	Amyloid Plaque 09/2022 - 12/2004
10	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 12/2004
6	Multiple Sclerosis 01/2020 - 10/2006
5	Epilepsy (Aura) 01/2022 - 01/2019
4	Inflammation (Inflammations) 11/2022 - 10/2006
4	Genetic Predisposition to Disease (Genetic Predisposition) 04/2021 - 03/2017
4	Autistic Disorder (Autism) 04/2020 - 03/2018
4	Dementia (Dementias) 01/2020 - 12/2004
4	Breast Neoplasms (Breast Cancer) 07/2017 - 09/2007
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 12/2004
3	Autism Spectrum Disorder 01/2020 - 03/2018
3	Cognitive Dysfunction 12/2019 - 01/2015
3	Hypersensitivity (Allergy) 08/2019 - 08/2010
2	Diabetes Mellitus 09/2022 - 02/2008
2	Rupture 01/2022 - 11/2013
2	Amyloid angiopathy 04/2020 - 01/2012
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2020 - 01/2019
2	Granuloma 01/2019 - 11/2015
2	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2017 - 02/2009
1	Neuroinflammatory Diseases 01/2021
1	Neuroblastoma 01/2021
1	Neurodevelopmental Disorders 04/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Catalepsy 12/2019
1	Mycoses (Diseases, Fungus) 05/2018
1	Amyloidosis 01/2018
1	Chronic Progressive Multiple Sclerosis 12/2017
1	Brain Diseases (Brain Disorder) 03/2017
1	Myalgia 01/2017
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Chronic Disease (Chronic Diseases) 01/2014
1	Genomic Instability 11/2013
1	Vascular Diseases (Vascular Disease) 06/2013
1	Neurologic Manifestations (Neurological Manifestations) 04/2013
1	Type 2 Diabetes Mellitus (MODY) 10/2010
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 06/2009
1	Macrophagic myofasciitis 02/2009
1	Leishmaniasis 11/2008
1	Mental Disorders (Mental Disorder) 06/2007

Drug/Important Bio-Agent (IBA)

45	AluminumIBA 01/2022 - 12/2001
17	Amyloid (Amyloid Fibrils)IBA 04/2021 - 06/2004
6	Peptides (Polypeptides)IBA 09/2021 - 06/2004
6	CopperIBA 01/2012 - 06/2004
5	IronIBA 01/2012 - 06/2004
4	Proteins (Proteins, Gene)FDA Link 04/2021 - 01/2020
4	MetalsIBA 01/2019 - 06/2004
4	VaccinesIBA 01/2019 - 02/2009
4	NeurotoxinsIBA 01/2019 - 02/2014
4	Amyloid beta-PeptidesIBA 01/2010 - 10/2002
3	Islet Amyloid PolypeptideIBA 09/2022 - 02/2008
3	GraphiteIBA 01/2020 - 10/2016
3	SaltsIBA 08/2019 - 01/2014
3	Silicic AcidIBA 05/2018 - 09/2006
3	Mineral WatersIBA 12/2017 - 09/2006
3	SiliconIBA 12/2017 - 01/2013
2	Flavin-Adenine Dinucleotide (FAD)IBA 04/2021 - 01/2020
2	Amino Acids FDA Link 08/2019 - 09/2005
2	4- chloro- 3- (2,4- dihydroxyphenylazo)- 2- hydroxybenzene- 1- sulfonic acidIBA 01/2019 - 10/2016
2	aluminum sulfate (alum)IBA 11/2015 - 04/2013
2	ZincIBA 11/2006 - 06/2004
1	Oxygen (Dioxygen)IBA 11/2022
1	SphingomyelinsIBA 01/2021
1	CeramidesIBA 01/2021
1	SphingolipidsIBA 01/2021
1	PresenilinsIBA 01/2020
1	AcidsIBA 01/2020
1	Amyloidogenic ProteinsIBA 01/2020
1	Cholinergic Agents (Cholinergics)IBA 12/2019
1	Protective AgentsIBA 12/2019
1	thioflavin TIBA 01/2019
1	Congo RedIBA 01/2019
1	AntigensIBA 01/2018
1	SolutionsIBA 01/2012
1	Serum Amyloid P-ComponentIBA 01/2012
1	AntibodiesIBA 08/2010
1	HLA-DRB1 Chains (HLA DRB1)IBA 08/2010
1	Prion ProteinsIBA 06/2009
1	AntiperspirantsIBA 09/2007
1	CosmeticsIBA 09/2007
1	Heroin (Diamorphine)IBA 06/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2006
1	Biomarkers (Surrogate Marker)IBA 10/2006
1	Thiobarbituric Acid Reactive SubstancesIBA 10/2006
1	alpha-SynucleinIBA 12/2004

Therapy/Procedure

6	Therapeutics 01/2014 - 06/2004
2	Immunotherapy 08/2019 - 01/2014
1	Subcutaneous Injections 01/2019
1	Mastectomy (Mammectomy) 10/2013
1	Chelation Therapy (Therapy, Chelation) 06/2004